Peter Zdziarski: Today is Chronic Disease Awareness Day
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
”Today is Chronic Disease Awareness Day.
Living with a rare bleeding disorder like Glanzmann Thrombasthenia is not easy. Bleeding episodes, hospital visits, anemia, fatigue, and uncertainty are realities that many of us face throughout our lives.
But our diagnosis should never define our potential. We are stronger than we know, and we can live fulfilling, meaningful lives.
Every advancement in treatment is meaningful, but we should never lose sight of the ultimate goal.
Managing symptoms is important, but treating the disorder itself is the goal.
Imagine children born with Glanzmann Thrombasthenia growing up without planning their lives around the next bleed.
Imagine parents no longer living with the constant worry of an emergency.
Imagine a future where this disease is part of history, not someone’s future.
Today, let’s recognize the challenges people with chronic diseases face while continuing to support the research that can change tomorrow.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders